Elevated symptoms of depression and anxiety among family members and friends of critically ill COVID-19 patients – an observational study of five cohorts across four countries
Helga Ask(Norwegian Institute of Public Health), Arna Hauksdóttir(University of Iceland), Per Magnus(Norwegian Institute of Public Health), Omid V. Ebrahimi(University of Oslo), Ole A. Andreassen(Oslo University Hospital), Anna Bára Unnarsdóttir(University of Iceland), Li Lu(Shenyang Pharmaceutical University), Charilaos Chourpiliadis(Karolinska Institutet), Archie Campbell(Vanderbilt University), Anikó Lovik(Leiden University), Daniel L. McCartney(Edinburgh Cancer Research), Sverre Urnes Johnson(Statistics Norway), Emma M. Frans(Karolinska Institutet), Jóhanna Jakobsdóttir(University of Miami), Ingibjörg Magnúsdóttir(University of Iceland), Asle Hoffart(Modum Bad – Gordon Johnsens stiftelse), Patrick F. Sullivan(University of North Carolina at Chapel Hill), Emily E. Joyce(Karolinska Institutet), Thor Aspelund(Icelandic Heart Association), Edda Björk Þórðardóttir(University of Iceland), Juan González‐Hijón(Karolinska Institutet), Chloe Fawns‐Ritchie(University of Dundee), David J. Porteous(Western General Hospital), Fang Fang(Jinshan Hospital of Fudan University), Lill Trogstad(Norwegian Institute of Public Health), Anna K. Kähler(Karolinska Institutet), Unnur Valdimarsdóttir(Harvard University)
Cited by 0
Related Papers
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
|Nature Genetics|2018|2.3k